pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract
Odactra
Allergic Rhino-Conjunctivitis
ALK-Abello Inc
0 catalysts
Marketed
standardized short ragweed pollen (Ambrosia artemisiifolia) allergen extract
Short Ragweed Pollen Allergenic Extract
Allergic Rhinitis
Jubilant HollisterStier LLC
0 catalysts
Marketed
streptomycin sulfate
Streptomycin Sulfate (streptomycin sulfate)
Bacteremia
X-GEN Pharmaceuticals DJB Inc
catalysts
← prev
page 219 of 231
next →
131
Pain89
Neurology1
0
Marketed
succimer
Chemet (succimer)
Lead Poisoning
Recordati Rare Diseases Inc
0 catalysts
Marketed
succinylcholine chloride
Succinylcholine Chloride (succinylcholine chloride)
General Anesthetic Effect
Nordic Pharma Inc
0 catalysts
Marketed
sugammadex sodium
Sugammadex Sodium (sugammadex sodium)
Anesthetic Effect
B. Braun Medical Inc
0 catalysts
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
0 catalysts
Marketed
sulconazole nitrate
Exelderm (sulconazole nitrate)
Tinea Corporis
$DERMJourney Medical Corp
0 catalysts
Marketed
sulfadiazine
Sulfadiazine (sulfadiazine)
Otitis Media
Epic Pharma LLC
0 catalysts
Marketed
sulfisoxazole
Sulfisoxazole (sulfisoxazole)
Bacterial (Pyogenic) Meningitis
Roxane Laboratories Inc
0 catalysts
Marketed
sulindac
Sulindac (sulindac)
Acute and Sub-Acute Bursitis
Epic Pharma LLC
0 catalysts
Marketed
sumatriptan
Sumatriptan (sumatriptan [INN])
Migraine
Florida Pharmaceutical Products LLC
0 catalysts
pre_registration
sumecigrel
Acute Coronary Syndrome
Jiangsu Vcare PharmaTech Co Ltd
0 catalysts
Marketed
sunitinib malate
Sunitinib Malate (sunitinib malate)
Gastrointestinal Stromal Tumor (GIST)
Wanbang Biopharmaceuticals Co Ltd
0 catalysts
Phase 2
sunobinop tosylate
Alcohol Use Disorder (AUD)
Imbrium Therapeutics LP
0 catalysts
Marketed
sunvozertinib
Zegfrovy (sunvozertinib)
Non-Small Cell Lung Cancer
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 3
surabgene lomparvovec
Wet (Neovascular / Exudative) Macular Degeneration
$ABBVAbbVie Inc.
0 catalysts
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
0 catalysts
Phase 1
surlorian fumarate
Unspecified Musculoskeletal Disorders
RyCarma Therapeutics Inc
0 catalysts
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
surufatinib
Solid Tumor
Fibroblast growth factor receptor 1Vascular endothelial growth factor receptor
$HCMHUTCHMED (China) Ltd
0 catalysts
Phase 3
survodutide
Liver Fibrosis
Glucagon-like peptide 1 receptorGlucagon receptor
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 2
sutacimig
sutacimig [INN]
Bleeding And Clotting Disorders
Hemab ApS
0 catalysts
Marketed
sutimlimab
Enjaymo (sutimlimab-jome)
Acquired (Autoimmune) Hemolytic Anemia
Bioverativ Inc
0 catalysts
Marketed
suvorexant
Belsomra (suvorexant)
Insomnia
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
suvratoxumab
Staphylococcus aureus Infections
Alpha-hemolysin
Aridis Pharmaceuticals Inc
0 catalysts
Phase 3
tadekinig alfa
tadekinig alfa [INN]
Hemophagocytic Lymphohistiocytosis
AB2 Bio Ltd
0 catalysts
Marketed
tafamidis
Vyndamax (tafamidis)
Familial Amyloid Cardiomyopathy
$PFEPFIZER INC
0 catalysts
Phase 3
tafasitamab
Monjuvi (tafasitamab)
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD19
$INCYINCYTE CORP
0 catalysts